Last 12 months
Inside the activity.
2 purchase rows · 40 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 12 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2021 Filed Jul 2, 2021 22:02 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 865 | $178.83 | $154,687.95 |
DisclosureSEC source: 0001567619-21-012954 · doc1.xml · nonDerivative · entry 7 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,035,906 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F7 · balance_after: Reflects a weighted average sale price of $178.83 per share, at prices ranging from $178.80 to $178.89 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 22:02 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 21,877 | $178.22 | $3,898,918.94 |
DisclosureSEC source: 0001567619-21-012954 · doc1.xml · nonDerivative · entry 6 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,036,771 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F6 · balance_after: Reflects a weighted average sale price of $178.22 per share, at prices ranging from $177.79 to $178.79 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 22:02 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 8,758 | $177.14 | $1,551,392.12 |
DisclosureSEC source: 0001567619-21-012954 · doc1.xml · nonDerivative · entry 5 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,058,648 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · balance_after: Reflects a weighted average sale price of $177.14 per share, at prices ranging from $176.76 to $177.71 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 22:02 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 4,411 | $176.04 | $776,512.44 |
DisclosureSEC source: 0001567619-21-012954 · doc1.xml · nonDerivative · entry 4 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,067,406 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · balance_after: Reflects a weighted average sale price of $176.04 per share, at prices ranging from $175.70 to $176.63 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 22:02 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 6,670 | $175.16 | $1,168,317.20 |
DisclosureSEC source: 0001567619-21-012954 · doc1.xml · nonDerivative · entry 3 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,071,817 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · balance_after: Reflects a weighted average sale price of $175.16 per share, at prices ranging from $174.70 to $175.68 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 22:02 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 41,277 | $174.05 | $7,184,261.85 |
DisclosureSEC source: 0001567619-21-012954 · doc1.xml · nonDerivative · entry 2 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078,487 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · balance_after: Reflects a weighted average sale price of $174.05 per share, at prices ranging from $173.68 to $174.60 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 22:02 UTC |
Du YingDirector · Chairwoman & CEO
|
Exercise / conversionOrdinary Shares | 111,111 | $0.60 | $66,666.60 |
DisclosureSEC source: 0001567619-21-012954 · doc1.xml · nonDerivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 17, 2021 Filed Jun 18, 2021 00:04 UTC |
Reinhart HaraldChief Medical Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001567619-21-012383 · doc1.xml · derivative · entry 6 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Ordinary Shares · 8,000 shares Expires 2027-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The options vest in equal annual installments over five years beginning on 09/20/2018, the first anniversary of the date of grant. Read SEC document |
| June 17, 2021 Filed Jun 18, 2021 00:04 UTC |
Reinhart HaraldChief Medical Officer
|
SaleOrdinary Shares | 8,000 | $161.64 | $1,293,120.00 |
DisclosureSEC source: 0001567619-21-012383 · doc1.xml · nonDerivative · entry 4 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 17, 2021 Filed Jun 18, 2021 00:04 UTC |
Reinhart HaraldChief Medical Officer
|
Exercise / conversionOrdinary Shares | 8,000 | $18.00 | $144,000.00 |
DisclosureSEC source: 0001567619-21-012383 · doc1.xml · nonDerivative · entry 3 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 16, 2021 Filed Jun 18, 2021 00:04 UTC |
Reinhart HaraldChief Medical Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $20.90 | $0.00 |
DisclosureSEC source: 0001567619-21-012383 · doc1.xml · derivative · entry 5 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Ordinary Shares · 8,000 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · derivative.exercise_date: The options vest in equal annual installments over five years beginning on 03/28/2019, the first anniversary of the date of grant. Read SEC document |
| June 16, 2021 Filed Jun 18, 2021 00:04 UTC |
Reinhart HaraldChief Medical Officer
|
SaleOrdinary Shares | 8,000 | $162.71 | $1,301,680.00 |
DisclosureSEC source: 0001567619-21-012383 · doc1.xml · nonDerivative · entry 2 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 16, 2021 Filed Jun 18, 2021 00:04 UTC |
Reinhart HaraldChief Medical Officer
|
Exercise / conversionOrdinary Shares | 8,000 | $20.90 | $167,200.00 |
DisclosureSEC source: 0001567619-21-012383 · doc1.xml · nonDerivative · entry 1 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 16, 2021 Filed Feb 14, 2022 21:06 UTC |
DIEKMAN JOHN DDirector
|
Tax withholdingOrdinary Shares | 3,515 | $142.25 | $500,008.75 |
DisclosureSEC source: 0000899243-22-006147 · doc5.xml · nonDerivative · entry 2 DIEKMAN JOHN D · CIK 0001240357 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,019 F1 · kind: Disposition of shares to Zai Lab Limited to cover taxes. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:01 UTC |
Fu TaoDirector · President & COO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $18.92 | $0.00 |
DisclosureSEC source: 0001567619-21-012382 · doc1.xml · derivative · entry 9 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Ordinary Shares · 10,000 shares Expires 2028-09-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F9 · derivative.exercise_date: The Stock Options vest in equal annual installments over five years beginning on 09/24/2019, the first anniversary of the date of grant. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:01 UTC |
Fu TaoDirector · President & COO
|
SaleOrdinary Shares | 701 | $169.12 | $118,553.12 |
DisclosureSEC source: 0001567619-21-012382 · doc1.xml · nonDerivative · entry 7 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,000 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F7 · price: Reflects a weighted average sale price of $169.12 per share, at prices ranging from $168.82 to $169.41 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:01 UTC |
Fu TaoDirector · President & COO
|
SaleOrdinary Shares | 300 | $167.74 | $50,322.00 |
DisclosureSEC source: 0001567619-21-012382 · doc1.xml · nonDerivative · entry 6 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,701 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F6 · price: Reflects a weighted average sale price of $167.74 per share, at prices ranging from $167.56 to $168.10 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:01 UTC |
Fu TaoDirector · President & COO
|
SaleOrdinary Shares | 607 | $166.65 | $101,156.55 |
DisclosureSEC source: 0001567619-21-012382 · doc1.xml · nonDerivative · entry 5 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,001 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · price: Reflects a weighted average sale price of $166.65 per share, at prices ranging from $166.51 to $167.36 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:01 UTC |
Fu TaoDirector · President & COO
|
SaleOrdinary Shares | 1,476 | $165.78 | $244,691.28 |
DisclosureSEC source: 0001567619-21-012382 · doc1.xml · nonDerivative · entry 4 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,608 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: Reflects a weighted average sale price of $165.78 per share, at prices ranging from $165.40 to $166.11 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:01 UTC |
Fu TaoDirector · President & COO
|
SaleOrdinary Shares | 4,564 | $164.80 | $752,147.20 |
DisclosureSEC source: 0001567619-21-012382 · doc1.xml · nonDerivative · entry 3 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,084 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: Reflects a weighted average sale price of $164.80 per share, at prices ranging from $164.38 to $165.35 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:01 UTC |
Fu TaoDirector · President & COO
|
SaleOrdinary Shares | 2,352 | $164.08 | $385,916.16 |
DisclosureSEC source: 0001567619-21-012382 · doc1.xml · nonDerivative · entry 2 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,648 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: Reflects a weighted average sale price of $164.08 per share, at prices ranging from $163.38 to $164.36 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:01 UTC |
Fu TaoDirector · President & COO
|
Exercise / conversionOrdinary Shares | 10,000 | $18.92 | $189,200.00 |
DisclosureSEC source: 0001567619-21-012382 · doc1.xml · nonDerivative · entry 1 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 297 | $180.80 | $53,697.60 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 16 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,008,653 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F16 · balance_after: Reflects a weighted average sale price of $180.80 per share, at prices ranging from $180.62 to $180.89 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 1,381 | $180.00 | $248,580.00 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 15 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,008,950 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F15 · balance_after: Reflects a weighted average sale price of $180.00 per share, at prices ranging from $179.50 to $180.42 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 983 | $178.62 | $175,583.46 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 14 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,010,331 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F14 · balance_after: Reflects a weighted average sale price of $178.62 per share, at prices ranging from $178.37 to $179.08 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 2,066 | $177.66 | $367,045.56 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 13 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,011,314 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F13 · balance_after: Reflects a weighted average sale price of $177.66 per share, at prices ranging from $177.36 to $178.27 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 2,936 | $176.90 | $519,378.40 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 12 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,013,380 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F12 · balance_after: Reflects a weighted average sale price of $176.90 per share, at prices ranging from $176.32 to $177.32 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 889 | $175.96 | $156,428.44 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 11 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,016,316 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F11 · balance_after: Reflects a weighted average sale price of $175.96 per share, at prices ranging from $175.30 to $176.30 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 911 | $174.68 | $159,133.48 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 10 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,017,205 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F10 · balance_after: Reflects a weighted average sale price of $174.68 per share, at prices ranging from $174.28 to $175.24 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:02 UTC |
Cho William Ki ChulChief Financial Officer
|
SaleOrdinary Shares | 1,416 | $180.69 | $255,857.04 |
DisclosureSEC source: 0001567619-21-011579 · doc1.xml · nonDerivative · entry 2 Cho William Ki Chul · CIK 0001835836 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 19, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 111,111 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · derivative · entry 17 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,222,498 Underlying: Ordinary Shares · 111,111 shares Expires 2025-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F17 · derivative.exercise_date: The Stock Options fully vested as of October 22, 2020. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 17,600 | $179.83 | $3,165,008.00 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 9 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,018,116 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F9 · balance_after: Reflects a weighted average sale price of $179.83 per share, at prices ranging from $179.39 to $180.27 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 14,510 | $178.87 | $2,595,403.70 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 8 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,035,716 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F8 · balance_after: Reflects a weighted average sale price of $178.87 per share, at prices ranging from $178.39 to $179.38 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 9,735 | $177.98 | $1,732,635.30 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 7 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050,226 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F7 · balance_after: Reflects a weighted average sale price of $177.98 per share, at prices ranging from $177.34 to $178.33 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 2,468 | $176.66 | $435,996.88 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 6 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,059,961 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F6 · balance_after: Reflects a weighted average sale price of $176.66 per share, at prices ranging from $176.29 to $177.20 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 7,087 | $175.79 | $1,245,823.73 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 5 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,062,429 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · balance_after: Reflects a weighted average sale price of $175.79 per share, at prices ranging from $175.25 to $176.23 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 14,451 | $174.65 | $2,523,867.15 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 4 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,069,516 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · balance_after: Reflects a weighted average sale price of $174.65 per share, at prices ranging from $174.245 to $175.245 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 24,868 | $173.79 | $4,321,809.72 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 3 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,083,967 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · balance_after: Reflects a weighted average sale price of $173.79 per share, at prices ranging from $173.24 to $174.24 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
SaleOrdinary Shares | 10,929 | $172.83 | $1,888,859.07 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 2 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,108,835 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · balance_after: Reflects a weighted average sale price of $172.83 per share, at prices ranging from $172.23 to $173.23 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:00 UTC |
Du YingDirector · Chairwoman & CEO
|
Exercise / conversionOrdinary Shares | 111,111 | $0.60 | $66,666.60 |
DisclosureSEC source: 0001567619-21-011578 · doc1.xml · nonDerivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairwoman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:02 UTC |
Cho William Ki ChulChief Financial Officer
|
SaleOrdinary Shares | 8,584 | $180.12 | $1,546,150.08 |
DisclosureSEC source: 0001567619-21-011579 · doc1.xml · nonDerivative · entry 1 Cho William Ki Chul · CIK 0001835836 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,416 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 19, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| May 26, 2021 Filed May 26, 2021 20:20 UTC |
Fu TaoDirector · President & COO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $18.92 | $0.00 |
DisclosureSEC source: 0001567619-21-011218 · doc1.xml · derivative · entry 7 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460,000 Underlying: Ordinary Shares · 10,000 shares Expires 2028-09-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · derivative.exercise_date: The Stock Options vest in equal annual installments over five years beginning on 09/24/2019, the first anniversary of the date of grant. Read SEC document |
| May 26, 2021 Filed May 26, 2021 20:20 UTC |
Fu TaoDirector · President & COO
|
SaleOrdinary Shares | 1,000 | $161.37 | $161,370.00 |
DisclosureSEC source: 0001567619-21-011218 · doc1.xml · nonDerivative · entry 5 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,000 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| May 26, 2021 Filed May 26, 2021 20:20 UTC |
Fu TaoDirector · President & COO
|
SaleOrdinary Shares | 300 | $160.14 | $48,042.00 |
DisclosureSEC source: 0001567619-21-011218 · doc1.xml · nonDerivative · entry 4 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,000 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| May 26, 2021 Filed May 26, 2021 20:20 UTC |
Fu TaoDirector · President & COO
|
SaleOrdinary Shares | 5,887 | $159.44 | $938,623.28 |
DisclosureSEC source: 0001567619-21-011218 · doc1.xml · nonDerivative · entry 3 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,300 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: Reflects a weighted average sale price of $159.44 per share, at prices ranging from $159.02 to $159.99 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 26, 2021 Filed May 26, 2021 20:20 UTC |
Fu TaoDirector · President & COO
|
SaleOrdinary Shares | 2,813 | $158.55 | $446,001.15 |
DisclosureSEC source: 0001567619-21-011218 · doc1.xml · nonDerivative · entry 2 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,187 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: Reflects a weighted average sale price of $158.55 per share, at prices ranging from $157.95 to $158.84 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 26, 2021 Filed May 26, 2021 20:20 UTC |
Fu TaoDirector · President & COO
|
Exercise / conversionOrdinary Shares | 10,000 | $18.92 | $189,200.00 |
DisclosureSEC source: 0001567619-21-011218 · doc1.xml · nonDerivative · entry 1 Fu Tao · CIK 0001644888 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| May 25, 2021 Filed May 27, 2021 00:18 UTC |
Reinhart HaraldChief Medical Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $20.90 | $0.00 |
DisclosureSEC source: 0001567619-21-011217 · doc1.xml · derivative · entry 6 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,000 Underlying: Ordinary Shares · 8,000 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · derivative.exercise_date: The options vest in equal annual installments over five years beginning on 03/28/2019, the first anniversary of the date of grant. Read SEC document |
| May 25, 2021 Filed May 27, 2021 00:18 UTC |
Reinhart HaraldChief Medical Officer
|
SaleOrdinary Shares | 8,000 | $161.66 | $1,293,280.00 |
DisclosureSEC source: 0001567619-21-011217 · doc1.xml · nonDerivative · entry 4 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| May 25, 2021 Filed May 27, 2021 00:18 UTC |
Reinhart HaraldChief Medical Officer
|
Exercise / conversionOrdinary Shares | 8,000 | $20.90 | $167,200.00 |
DisclosureSEC source: 0001567619-21-011217 · doc1.xml · nonDerivative · entry 3 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.